A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients using ColoPrint
Conditions
Colon Cancer
What is the purpose of this trial?
Participation Guidelines
- Age:
- 18 Years and older
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Onconova Therapeutics, Inc.
- Dates:
- August 2011
- Last Updated:
- Study HIC#:
- 1104008300
Clinicaltrials.gov ID: Yale1808391
